Mobile Application for Cardiovascular Risk Treatment (iSMART-CV)
Hypertension, Hyperlipidemias, Chronic Disease
About this trial
This is an interventional health services research trial for Hypertension focused on measuring smart healthcare
Eligibility Criteria
Inclusion Criteria: health insurance subscribers who are aged 20-54 years 24-hour ambulatory systolic BP 130-159 mmHg or serum LDL ≥130 mg/dl Android smartphone users who can use ICT-based helathcare application no use of anti-hypertensive or lipid-lowering drugs for ≥3 months prior to screening subjects who are considered appropriate to be managed with lifestyle modification for 12 weeks Subject who understands the purpose of the study and signs with informed consent form Exclusion Criteria: 24-hour ambulatory systolic or diastolic BP >160 mmHg or > 110 mmHg underlying cardiovascular disease (ischemic heart disease, heart failure, aortic disease, valvular heart disease, arrhythmia, cardiomyopathy, etc.) underlying cerebrovascular disease (stroke, cerebral infarction or hemorrhage, cerebral aneurysm, etc.) chronic renal disease peripheral vascular disease pregnancy secondary hypertension atrial fibrillation or flutter severe bradyarrhythmia difficulty in BP measurement by smart watch difference in systolic BP measurements from both arms > 10mmHg life expectancy < 2 years medical conditions that would limit adherence to participation (as confirmed by physicians)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
smart group
control group
Smartphone App-based healthcare
a book-based self-education